Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 187
10
Diseases
2
Unique genes
0.468
Avg. similarity score
Cutis laxa, autosomal recessive, 3a
Most-connected disease (8 links)
Disease
Searched: Spastic paraplegia 9b, autosomal recessive
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Spastic paraplegia 9b, autosomal recessive
Cutis laxa, autosomal recessive, 3a
Cutis laxa, corneal clouding, and mental retardation
De barsy syndrome
Developmental disorder-joint hypermobility-skin laxity with or without metabolic abnormalities
P5CS deficiency
Complex spastic paraplegia
Cutis laxa, autosomal dominant 3
Spastic paraplegia 9
Spastic paraplegia 81, autosomal recessive
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Cutis laxa, autosomal recessive, 3a | 8 | 8 | 1 |
| Cutis laxa, corneal clouding, and mental retardation | 8 | 8 | 1 |
| De barsy syndrome | 8 | 8 | 1 |
| Developmental disorder-joint hypermobility-skin laxity with or without metabolic abnormalities | 8 | 8 | 1 |
| P5CS deficiency | 8 | 8 | 1 |
| Complex spastic paraplegia | 6 | 6 | 2 |
| Cutis laxa, autosomal dominant 3 | 5 | 5 | 1 |
| Spastic paraplegia 9 | 5 | 5 | 1 |
| Spastic paraplegia 9b, autosomal recessive | 5 | 5 | 1 |
| Spastic paraplegia 81, autosomal recessive | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ALDH18A1 | 9 / 10 | Complex spastic paraplegia, Cutis laxa, autosomal dominant 3, Cutis laxa, autosomal recessive, 3a, Cutis laxa, corneal clouding, and mental retardation and 5 more |
| SELENOI | 2 / 10 | Complex spastic paraplegia, Spastic paraplegia 81, autosomal recessive |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Phosphonate and phosphinate metabolism | KEGG | 1 / 6 | 1,001× | 9.99e-4 | 1.13e-2 ✓ sig. |
| Synthesis of PE | Reactome | 1 / 12 | 500× | 2.00e-3 | 1.90e-2 ✓ sig. |
| Glutamate and glutamine metabolism | Reactome | 1 / 14 | 429× | 2.33e-3 | 2.13e-2 ✓ sig. |
| Arginine and proline metabolism | KEGG | 1 / 50 | 120× | 8.31e-3 | 5.07e-2 |
| Ether lipid metabolism | KEGG | 1 / 50 | 120× | 8.31e-3 | 5.07e-2 |
| Biosynthesis of amino acids | KEGG | 1 / 75 | 80.1× | 1.25e-2 | 6.50e-2 |
| Glycerophospholipid metabolism | KEGG | 1 / 102 | 58.9× | 1.69e-2 | 7.79e-2 |
| Metabolic pathways | KEGG | 2 / 1,563 | 7.7× | 1.69e-2 | 7.79e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| ornithine biosynthetic process | GO:0006592 | 1 / 1 | 9,344× | 1.07e-4 | 3.25e-3 ✓ sig. |
| citrulline biosynthetic process | GO:0019240 | 1 / 4 | 2,336× | 4.28e-4 | 8.53e-3 ✓ sig. |
| L-proline biosynthetic process | GO:0055129 | 1 / 6 | 1,557× | 6.42e-4 | 1.11e-2 ✓ sig. |
| glycerophospholipid biosynthetic process | GO:0046474 | 1 / 7 | 1,335× | 7.49e-4 | 1.23e-2 ✓ sig. |
| ether lipid biosynthetic process | GO:0008611 | 1 / 8 | 1,168× | 8.56e-4 | 1.33e-2 ✓ sig. |
| phosphatidylethanolamine biosynthetic process | GO:0006646 | 1 / 12 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| response to temperature stimulus | GO:0009266 | 1 / 14 | 667× | 1.50e-3 | 1.82e-2 ✓ sig. |
| glutamate metabolic process | GO:0006536 | 1 / 15 | 623× | 1.60e-3 | 1.88e-2 ✓ sig. |
| amino acid biosynthetic process | GO:0008652 | 1 / 27 | 346× | 2.89e-3 | 2.55e-2 ✓ sig. |
| phospholipid biosynthetic process | GO:0008654 | 1 / 58 | 161× | 6.20e-3 | 3.70e-2 ✓ sig. |
| myelination | GO:0042552 | 1 / 73 | 128× | 7.80e-3 | 4.13e-2 ✓ sig. |
| lipid metabolic process | GO:0006629 | 1 / 840 | 11.1× | 8.79e-2 | 1.52e-1 |